NIH VideoCast - Animal Model Development Workshop (Day 1)

Skip Navigation

Animal Model Development Workshop (Day 1)

Loading... Loading video...

792 Views

Chapter		Description	Position
1		Introduction and Overview - Judy Hewitt, NIAID	0:00:04
2		Common themes: Animal Models for CBRN Countermeasures - George Korch, ASPR/HHS	0:19:32
3		Bridging animal and clinical data - Lisa Hensley, MCMi/FDA	0:51:38
4		Experience with rare clinical diseases - Simon Mardell (UK)	1:17:18
5		Product Development Under the “Animal Rule” - Rosemary Roberts CDER/ FDA	2:07:56
6		Model Qualification as a voluntary, product independent, mechanism - Jerry Davis, CDER/FDA	2:42:15
7		Interagency Coordination of Animal Model Development and Qualification - Phil Ferro, ASPR/HHS	3:09:51
8		Consistent euthanasia criteria - Estella Jones D.V.M.	3:32:06
9		Supportive care overview: blending supportive care considerations with experimental design - Jim Swearengen , NBACC/DHS	4:02:33
10		Supportive care case Studies: Ebola - Mark Kortepeter (USUHS)	4:39:26
11		Supportive care case Studies: Rad/Nuc - Tom MacVittie (U of MD)	5:10:50
12		Open Discussion	5:42:11

Air date:	Monday, September 17, 2012, 8:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 792 (188 Live, 604 On-demand)
Category:	Conferences
Runtime:	06:04:30
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The Animal Model Development Workshop will explore the scientific and regulatory challenges of developing medical countermeasures (MCM) under the FDA "Animal Rule” (21 CFR 314.600 for drugs; 21 CFR 601.90 for biological products). The goals of this workshop are to highlight the significant progress made in animal model development for MCMs, review recent case studies of products under development using animal models, and capture lessons learned to inform future animal model development efforts. In addition, the workshop will provide a forum to discuss current challenges and identify potential solutions or mitigation strategies. For more information go to https://respond.niaid.nih.gov/conferences/AMDW/Pages/default.aspx

NLM Title:	Animal Model Development Workshop / NIAID, FDA, BARDA, TMT, DTRA.
Author:	Animal Model Development Workshop
Publisher:
Abstract:	(CIT): The Animal Model Development Workshop will explore the scientific and regulatory challenges of developing medical countermeasures (MCM) under the FDA "Animal Rule" (21 CFR 314.600 for drugs; 21 CFR 601.90 for biological products). The goals of this workshop are to highlight the significant progress made in animal model development for MCMs, review recent case studies of products under development using animal models, and capture lessons learned to inform future animal model development efforts. In addition, the workshop will provide a forum to discuss current challenges and identify potential solutions or mitigation strategies.
Subjects:	Models, Animal
Publication Types:	Congress Webcast

NLM Classification:	QY 58
NLM ID:	101595140
CIT Live ID:	11813
Permanent link:	https://videocast.nih.gov/watch=11813

Related Videos...